Alternate-Day Buprenorphine Administration. Phase IV - 5

Clinical trial NCT00000223 · COMPLETED

Trial details

NCT number: NCT00000223
Sponsor: National Institute on Drug Abuse (NIDA)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Opioid-Related Disorders

Start date: 1993-06-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.